| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 20 |
| 1 | SODIUM OXYBATE | 16 |
| 2 | LISINOPRIL | 15 |
| 3 | ADALIMUMAB | 14 |
| 4 | FUROSEMIDE | 14 |
| 5 | TOFACITINIB | 13 |
| 6 | HYDROXYCHLOROQUINE | 12 |
| 7 | LEFLUNOMIDE | 12 |
| 8 | METHOTREXATE | 12 |
| 9 | METHOTREXATE SODIUM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIMETHYL SULFOXIDE | 1 | 0.0041 |
| 1 | OXYMETAZOLINE HCL | 1 | 0.0018 |
| 2 | OSILODROSTAT | 4 | 0.0018 |
| 3 | PSYLLIUM HUSK | 2 | 0.0015 |
| 4 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 1 | 0.0014 |
| 5 | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | 1 | 0.0014 |
| 6 | MEFENAMIC ACID | 2 | 0.0009 |
| 7 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 8 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 | 0.0009 |
| 9 | TAZAROTENE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 1 | Corticosteroid [EPC] | 18 |
| 2 | Benzodiazepine [EPC] | 15 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 14 |
| 4 | GLP-1 Receptor Agonist [EPC] | 14 |
| 5 | Loop Diuretic [EPC] | 14 |
| 6 | Aminosalicylate [EPC] | 12 |
| 7 | Antirheumatic Agent [EPC] | 12 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 1 | Intestinal Lipase Inhibitor [EPC] | 10 | 0.0004 |
| 2 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 3 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 4 | Photoenhancer [EPC] | 1 | 0.0003 |
| 5 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 6 | Potassium-sparing Diuretic [EPC] | 2 | 0.0001 |
| 7 | Aminosalicylate [EPC] | 12 | 0.0001 |
| 8 | Non-narcotic Antitussive [EPC] | 2 | 0.0001 |
| 9 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |